Sort
30,917 grants matching “tumor microenvironment”
Ovarian Cancer Chemoprevention
$465,809Doris Mangiaracina Benbrook · University Of Oklahoma Hlth Sciences Ctr · R01 · FY2018 · CA
Targeting HSP70 for MelanomaTherapy
$465,781Maureen E Murphy · Wistar Institute · P01 · FY2021 · CA
The roles of a unique GTP-binding protein/crosslinking enzyme in disease
$465,676Richard A. Cerione · Cornell University · R01 · FY2020 · CA
The roles of a unique GTP-binding protein/crosslinking enzyme in disease
$465,660Richard A. Cerione · Cornell University · R01 · FY2018 · CA
Repurposing TRM for tumor immunotherapy
$465,651David Masopust · University Of Minnesota · R01 · FY2024 · CA
The roles of a unique GTP-binding protein/crosslinking enzyme in disease
$465,651Richard A. Cerione · Cornell University · R01 · FY2017 · CA
The role of GPR133 in glioblastoma
$465,623Dimitris G. Placantonakis · New York University School Of Medicine · R01 · FY2018 · NS
Microenvironmental contribution of the Choroid Plexus and Cerebral Spinal Fluid in breast to brain metastases
$465,610Josh Neman-Ebrahim · University Of Southern California · R01 · FY2019 · CA
Role of CREBBP missense mutations in lymphomagenesis
$465,588Laura Pasqualucci · Columbia University Health Sciences · R01 · FY2023 · CA
Image-based Systems Biology of Vascular Co-option in Brain Tumors
$465,528Arvind P Pathak · Johns Hopkins University · R01 · FY2023 · CA
EPIGENETIC REPROGRAMMING OF T CELL EXHAUSTION TO ENHANCE TUMOR IMMUNOTHERAPY
$465,506Benjamin Alan Youngblood · St. Jude Children'S Research Hospital · R01 · FY2025 · CA
Role of immune regulation in colorectal cancer chemotherapeutic response
$465,478Jun Lu · Yale University · R01 · FY2024 · CA
Targeting the EGFR-PI3K/mTOR Signaling Circuitry: A Network-Based Approach for Oral Cancer Precision Therapy
$465,473J. Silvio Gutkind · University Of California, San Diego · R01 · FY2019 · DE
S100A4 mediated immune suppression in GBM
$465,405Kyuson Yun · Methodist Hospital Research Institute · R01 · FY2021 · NS
CRAF-mediated vascular resistance to cancer therapies
$465,256David A Cheresh · University Of California, San Diego · R01 · FY2016 · CA
CRAF-mediated vascular resistance to cancer therapies
$465,256David A Cheresh · University Of California, San Diego · R01 · FY2017 · CA
CRAF-mediated vascular resistance to cancer therapies
$465,256David A Cheresh · University Of California, San Diego · R01 · FY2018 · CA
CRAF-mediated vascular resistance to cancer therapies
$465,256David A Cheresh · University Of California, San Diego · R01 · FY2015 · CA
Metabolic basis of ARID1A-mutated ovarian cancer
$465,225Rugang Zhang · University Of Tx Md Anderson Can Ctr · R01 · FY2024 · CA
Defining epigenetic signaling to reshape pancreatic tumor microenvironment
$465,156Jiaqi Shi · University Of Michigan At Ann Arbor · R37 · FY2025 · CA
Neural Niche in Promoting Brain Metastatic Tumor Progression
$465,146Siyuan Zhang · Ut Southwestern Medical Center · R01 · FY2025 · CA
ADPKD: Understanding immunosuppression mechanisms and discovering treatment
$465,096Xiaogang Li · Mayo Clinic Rochester · R01 · FY2021 · DK
ADPKD: Understanding immunosuppression mechanisms and discovering treatment
$465,096Xiaogang Li · Mayo Clinic Rochester · R01 · FY2022 · DK
ADPKD: Understanding immunosuppression mechanisms and discovering treatment
$465,096Xiaogang Li · Mayo Clinic Rochester · R01 · FY2023 · DK
NF-kB Regulation of the Muscle Microenvironment in Cancer Cachexia
$465,055Denis C Guttridge · Medical University Of South Carolina · R01 · FY2021 · AR